Simplified regulatory pathways are key for the future of biosimilars in Europe
This year marks two decades since the first biosimilar was approved in Europe in 2006. Since then, approximately 165 European…
This year marks two decades since the first biosimilar was approved in Europe in 2006. Since then, approximately 165 European…